Routine pharmacological venous thromboembolism prophylaxis in frail older hospitalised patients: Where is the evidence?

Age and Ageing

Volumn 42, Issue 4, 2013, Pages 428-434

  Greig, Matthew F G ^a   Rochow, Stuart B ^a   Crilly, Michael A ^b   Mangoni, Arduino A ^a  

^a WOODEND HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Deep vein thrombosis; Elderly; Older people; Prophylaxis; Pulmonary embolism; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; ENOXAPARIN; FONDAPARINUX; PLACEBO;

AGING; ARTICLE; BLEEDING DISORDER; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); DRUG FATALITY; FRAIL ELDERLY; HOSPITAL PATIENT; HUMAN; INCIDENCE; LUNG EMBOLISM; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; VENOUS THROMBOEMBOLISM;

DEEP VEIN THROMBOSIS; ELDERLY; OLDER PEOPLE; PROPHYLAXIS; PULMONARY EMBOLISM; VENOUS THROMBOEMBOLISM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; EVIDENCE-BASED MEDICINE; FRAIL ELDERLY; GUIDELINE ADHERENCE; HEALTH SERVICES FOR THE AGED; HEMORRHAGE; HUMANS; INCIDENCE; INPATIENTS; MIDDLE AGED; ODDS RATIO; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84879857709     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/aft041     Document Type: Article

References (15)

1. National Institute for Health and Clinical Excellence. Venous thromboembolism: reducing the risk. NICE clinical guideline 92. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. NICE, 2010. Available at: http://guidance. nice.org.uk/CG92/NICEGuidance/pdf/English (17 January 2013, date last accessed).
2. Scottish Intercollegiate Guidelines Network. SIGN 122: prevention and management of venous thromboembolism. A national clinical guideline. SIGN, 2010. Available at: http:// www.sign.ac.uk/guidelines/fulltext/122/index.html (17 January 2013, date last accessed).
3. The Royal College of Physicians. Prevention of venous thromboembolism. The four professions position statement. RCP, 2012. Available at: http://www.rcplondon.ac.uk/pressreleases/ royal-colleges-advise-professions-cost-effectiveprevention- vte (17 January 2013, date last accessed).
4. Donald I, Hunt B. Thromboprophylaxis for the prevention of hospital-acquired venous thromboembolism. British Geriatrics Society 2012. Available at: http://www.bgs.org.uk/ index.php?option=com_content&view=article&id=1999: bpgthromporphylaxis&catid=12:goodpractice&Itemid=106 (17 January 2013, date last accessed).
5. House of Commons Health Committee. The Prevention of Venous Thromboembolism in Hospitalised Patients. Second Report of Session 2004-05. HC 99. London: The Stationery Office Limited, 2005.
6. Department of Health. Report of the independent expert working group on the prevention of venous thromboembolism in hospitalised patients. 2007. Available at: http://www. dh.gov.uk/en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH_073944 (17 January 2013, date last accessed).
7. Kopcke D, Harryman O, Benbow EW et al. Mortality from pulmonary embolism is decreasing in hospital patients. J R Soc Med 2011; 104: 327-31.
8. Samama MM, Cohen AT, Darmon JV et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med 1999; 341: 793-800.
9. Dentali F, Douketis JD, Gianni M et al. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007; 146: 278-88.
10. Lederle FA, Zylla D, MacDonald R, Wilt TJ. Venous thromboembolism prophylaxis in hospitalised medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med 2011; 155: 602-15.
11. Kakkar AJ, Cimminiello C, Goldhaber SZ et al. Low molecular weight heparin and mortality in acutely ill medical patients. New Engl J Med 2011; 365: 2463-72.
12. Alikhan R, Cohen AT, Combe S et al. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis 2003; 14: 341-6.
13. Leizorovicz A, Cohen AT, Turpie AG et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely medical patients. Circulation 2004; 110: 874-9.
14. Kucher N, Leizorovicz A, Vaitkus PT et al. Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalised patients. Arch Intern Med 2005; 165: 341-5.
15. Cohen AT, Davidson BL, Gallus AS et al. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ 2006; 332: 325-9.